Dr. Raphael Chinedu Dikas, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 610 North Preston Road, Suite 4, Gunter, TX 75058 Phone: 903-228-0228 |
News Archive
Reverse Medical Corporation announced today that it has received US Food and Drug Administration (FDA) conditional approval to begin a neurothrombectomy IDE study for its ReStoreā¢ Microcatheter at twenty US centers. The study is planned to begin enrollment in US and European hospitals following investigating study center Institutional Review Board (IRB) approvals.
As a candidate, President Donald Trump promised abortion opponents four specific actions to "advance the rights of unborn children and their mothers."
FDA issued a warning in February 2004, about adverse events experienced by four teenagers after they consumed Green Hornet Liquid that contained high levels of the over-the-counter drugs diphenhydramine and dextromethorphan.
Inspire Pharmaceuticals, Inc. announced today financial results for the second quarter ended June 30, 2010, reporting a net loss of $8.8 million or ($0.11) per share, an improvement from the second quarter of 2009 during which the Company incurred a net loss of $9.5 million or ($0.17) per share.
SRI International, an independent nonprofit research and development institute, announced today that a new Neurodegenerative Diseases Research Program has been established within its Center for Health Sciences. This new SRI group of neuroscientists and researchers working at the cutting edge of science brings $6.2 million of funding from the National Institutes of Health (NIH), including the National Institute of Neurological Disorders and Stroke (NINDS), the National Institute of Environmental Health Sciences (NIEHS), and National Institute of General Medical Sciences (NIGMS).
› Verified 8 days ago